Only 17 percent of Americans now say they won't get a COVID-19 vaccine

As COVID-19 vaccines continue rolling out throughout the United States, a new poll suggests vaccine hesitancy is on the decline.
In a Census Bureau survey conducted in coordination with the Centers for Disease Control and Prevention, 17 percent of adults said they definitely or probably wouldn't get vaccinated against COVID-19, a decline from 22 percent in January, The Wall Street Journal reports.
The decline was more prominent among those who said they "probably" would not get vaccinated, as 13 percent said as much in January compared to nine percent in March. Eight percent of respondents said they "definitely" won't get the vaccine, down only one point from nine percent in January.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The poll also breaks down the responses by state, and though hesitancy was highest in the South, there were notable declines in Alabama, Louisiana, North Carolina, and South Carolina, the Journal notes. Among Black Americans, 22 percent said they probably or definitely wouldn't get the vaccine, down from 34 percent in January.
Meanwhile, a separate poll released by the Kaiser Family Foundation showed 13 percent of respondents said they will "definitely not" get vaccinated. Among Republicans and white evangelical Christians, almost 30 percent said they wouldn't get the vaccine. The poll also showed, though, that 55 percent of Black adults either had received their vaccine or soon planned to do so, which was up 14 percentage points from February.
The Census Bureau's latest survey spoke with almost 80,000 U.S. adults between March 3 and March 15. Read more at The Wall Street Journal.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
US foodies brace for tariff war
Under The Radar Shoppers stocking up on imported olive oil, maple syrup and European wine as price hikes loom
By Chas Newkey-Burden, The Week UK Published
-
How Canadian tariffs could impact tourism to the US
In the Spotlight Canadians represent the largest group of foreign visitors to the United States. But they may soon stop visiting.
By Justin Klawans, The Week US Published
-
Entitlements: DOGE goes after Social Security
Feature Elon Musk is pushing false claims about Social Security fraud
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published